🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Gastrointestinal (GI) symptoms including vomiting, nausea, abdominal pain, ...
Status
Terminated
Location
Department of Hepatology and Gastroenterology, Aarhus University Hospital
Start Date
2015-10
Trial ID
NCT02573519
A prospective, multi-center, non-randomized, pivotal study to assess the sa...
Status
Unknown
Location
Multiple Locations
Start Date
2024-12-01
Trial ID
NCT04107662
Treatments Being Tested
The aim of this study is to determine the effects of the level of metabolit...
Status
Completed
Location
Trakya University
Start Date
2019-12-10
Trial ID
NCT04584827
Treatments Being Tested
This phase I trial studies the side effects of pembrolizumab in treating pa...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-04-04
Trial ID
NCT02595866
The aim of the study is to evaluate the accuracy and reproducibility of the...
Status
Completed
Location
Universitair Ziekenhuis Brussel
Start Date
2017-11-28
Trial ID
NCT03551158
Treatments Being Tested
Purpose To investigate the ability of 18F-FDG PET/CT imaging to detect meta...
Status
Recruiting
Location
Drammen Hospital - Vestre Viken HF
Start Date
2023-02-16
Trial ID
NCT05730608
Treatments Being Tested
This phase II trial tests how well trabedersen (OT-101) in combination with...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-01
Trial ID
NCT05935774
This ALCHEMIST trial studies genetic testing in screening patients with sta...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-09-26
Trial ID
NCT02194738
Treatments Being Tested
This phase I/II trial tests the side effects and best dose of abemaciclib w...
Status
Recruiting
Location
UT MD Anderson Cancer Center
Start Date
2026-03-18
Trial ID
NCT06498648
Treatments Being Tested